von Willebrand factor and fibrinogen

被引:25
作者
Ruggeri, Zaverio M. [1 ,2 ]
机构
[1] Scripps Res Inst, Roon Res Lab Arteriosclerosis & Thrombosis, Div Expt Thrombosis & Hemostasis, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Comm Vasc Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1016/0955-0674(93)90041-N
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Progress in understanding the structure and function of von Willebrand factor and fibrinogen has provided new insights into the mechanisms of hemostasis and thrombosis. This, in turn, has generated concepts that may become applicable to the diagnosis and treatment of occlusive vascular diseases and bleeding disorders, both congenital and acquired.
引用
收藏
页码:898 / 906
页数:9
相关论文
共 56 条
[31]   MOLECULAR-BASIS OF FIBRINOGEN NAPLES ASSOCIATED WITH DEFECTIVE THROMBIN BINDING AND THROMBOPHILIA - HOMOZYGOUS SUBSTITUTION OF B-BETA 68 ALA-]THR [J].
KOOPMAN, J ;
HAVERKATE, F ;
LORD, ST ;
GRIMBERGEN, J ;
MANNUCCI, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :238-244
[32]   FIBRINOGEN MEDIATES LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIUM THROUGH AN ICAM-1-DEPENDENT PATHWAY [J].
LANGUINO, LR ;
PLESCIA, J ;
DUPERRAY, A ;
BRIAN, AA ;
PLOW, EF ;
GELTOSKY, JE ;
ALTIERI, DC .
CELL, 1993, 73 (07) :1423-1434
[33]   DEFECTS IN TYPE-IIA VONWILLEBRAND DISEASE - A CYSTEINE-509 TO ARGININE SUBSTITUTION IN THE MATURE VONWILLEBRAND-FACTOR DISRUPTS A DISULFIDE LOOP INVOLVED IN THE INTERACTION WITH PLATELET GLYCOPROTEIN-IB-IX [J].
LAVERGNE, JM ;
DEPAILLETTE, L ;
BAHNAK, BR ;
RIBBA, AS ;
FRESSINAUD, E ;
MEYER, D ;
PIETU, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) :66-72
[34]   THE PRO-POLYPEPTIDE OF VONWILLEBRAND-FACTOR IS REQUIRED FOR THE FORMATION OF A FUNCTIONAL FACTOR-VIII-BINDING SITE ON MATURE VONWILLEBRAND-FACTOR [J].
LEYTE, A ;
VOORBERG, J ;
VANSCHIJNDEL, HB ;
DUIM, B ;
PANNEKOEK, H ;
VANMOURIK, JA .
BIOCHEMICAL JOURNAL, 1991, 274 :257-261
[35]   VONWILLEBRAND PROTEIN FACILITATES PLATELET INCORPORATION IN POLYMERIZING FIBRIN [J].
LOSCALZO, J ;
INBAL, A ;
HANDIN, RI .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (04) :1112-1119
[36]   FIBRINOGEN LIMA - A HOMOZYGOUS DYSFIBRINOGEN WITH AN A-ALPHA-ARGININE-141 TO SERINE SUBSTITUTION ASSOCIATED WITH EXTRA N-GLYCOSYLATION AT A-ALPHA-ASPARAGINE-139 - IMPAIRED FIBRIN GEL FORMATION BUT NORMAL FIBRIN-FACILITATED PLASMINOGEN ACTIVATION CATALYZED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
MAEKAWA, H ;
YAMAZUMI, K ;
MURAMATSU, S ;
KANEKO, M ;
HIRATA, H ;
TAKAHASHI, N ;
AROCHAPINANGO, CL ;
RODRIGUEZ, S ;
NAGY, H ;
PEREZREQUEJO, JL ;
MATSUDA, M .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :67-76
[37]  
MATSUI T, 1992, J BIOL CHEM, V267, P8723
[38]  
PARKER RI, 1987, BLOOD, V70, P1589
[39]   SIGNAL TRANSDUCTION BY THE PLATELET INTEGRIN ALPHA-IIB-BETA-3 - INDUCTION OF CALCIUM OSCILLATIONS REQUIRED FOR PROTEIN-TYROSINE PHOSPHORYLATION AND LIGAND-INDUCED SPREADING OF STABLY TRANSFECTED CELLS [J].
PELLETIER, AJ ;
BODARY, SC ;
LEVINSON, AD .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (09) :989-998
[40]   OPTIMIZATION OF A RECOMBINANT VONWILLEBRAND-FACTOR FRAGMENT AS AN ANTAGONIST OF THE PLATELET GLYCOPROTEIN-IB RECEPTOR [J].
PRIOR, CP ;
CHU, V ;
CAMBOU, B ;
DENT, JA ;
EBERT, B ;
GORE, R ;
HOLT, J ;
IRISH, T ;
LEE, T ;
MITSCHELEN, J ;
MCCLINTOCK, RA ;
SEARFOSS, G ;
RICCA, GA ;
TARR, C ;
WEBER, D ;
WARE, JL ;
RUGGERI, ZM ;
HRINDA, M .
BIO-TECHNOLOGY, 1993, 11 (06) :709-713